Fidelity Investments’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-750
Closed -$1.95K 5520
2024
Q3
$1.95K Buy
+750
New +$2.08K ﹤0.01% 4816
2023
Q3
Sell
-1,409
Closed -$9.1K 5265
2023
Q2
$9.1K Sell
1,409
-41,759
-97% -$285K ﹤0.01% 4174
2023
Q1
$325K Sell
43,168
-13,088
-23% -$119K ﹤0.01% 2832
2022
Q4
$570K Sell
56,256
-53,277
-49% -$615K ﹤0.01% 2678
2022
Q3
$1.08M Buy
109,533
+72,994
+200% +$801K ﹤0.01% 2585
2022
Q2
$389K Buy
+36,539
New +$309K ﹤0.01% 2922
2022
Q1
Sell
-55,200
Closed -$789K 4902
2021
Q4
$789K Sell
55,200
-1,900
-3% -$28.8K ﹤0.01% 2713
2021
Q3
$1.15M Sell
57,100
-1,000
-2% -$17.7K ﹤0.01% 2673
2021
Q2
$1.28M Sell
58,100
-3,600
-6% -$99.3K ﹤0.01% 2620
2021
Q1
$2.1M Sell
61,700
-196,900
-76% -$7.84M ﹤0.01% 2463
2020
Q4
$10.4M Buy
+258,600
New +$11.8M ﹤0.01% 1960

Other funds holding ABCL